Health Sciences Acquisitions Corporation 2 (HSAQ) Research

Health Sciences Acquisitions Corporation 2 currently lacks active business operations. Its primary objective is to complete a strategic business combination, such as a merger or acquisition, with one or more enterprises. These target businesses will operate within the biopharmaceutical or medical technology sectors and be located in North America or Europe. The company was established in 2020 and is headquartered in New York, New York.

Market snapshot

Symbol
HSAQ
Price
$13.31
Day change
+24.16%
Market cap
$149.2M
P/E ratio
-15218.54x
52-week range
9.41-13.8
Sector
Financial Services
Industry
Shell Companies

Peer companies

  • Aurora Acquisition Corp. (AURC)
  • Blockchain Coinvestors Acquisition Corp. I (BCSA)
  • HPX Corp. (HPX)
  • Landcadia Holdings IV, Inc. (LCA)
  • LAVA Medtech Acquisition Corp. (LVAC)
  • Cartesian Growth Corporation II (RENE)
  • Ross Acquisition Corp II (ROSS)
  • 10X Capital Venture Acquisition Corp. III (VCXB)

Recent insider activity

  • Papandreou George — trade (0 shares) on 2023-09-19
  • Papandreou George — trade (50000 shares) on 2023-09-19
  • Papandreou George — trade (23622 shares) on 2023-09-19
  • Papandreou George — trade (6278 shares) on 2023-09-19
  • Papandreou George — trade (23250 shares) on 2023-09-19

Open Health Sciences Acquisitions Corporation 2 (HSAQ) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.